Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar

A retrospective analysis of people on ART for more than 9 years followed by a cross-sectional survey

Abstract

Objective is to study the long-term clinical, immunological and virological outcomes among people living with HIV on antiretroviral therapy (ART) in Myanmar.

Method is a retrospective analysis of people on ART for >9 years followed by a cross-sectional survey among the patients in this group who remained on ART at the time of the survey. Routinely collected medical data established the baseline clinical and demographic characteristics for adult patients initiating ART between 2004 and 2006. Patients remaining on ART between March-August 2015 were invited to participate in a survey assessing clinical, virological, immunological, and biochemical characteristics.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Bermúdez-Aza E, Shetty S, Ousley J, Kyaw N, Soe T, Soe K, Mon P, Tun K, Ciglenecki I, Cristofani S, Fernandez M. patients on antiretroviral therapy in southern Myanmar. PLoS One. 2018;13(2):e0191695.

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar

Updates to this page

Published 8 February 2018